Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Michael Dustin, Director of Research at the Kennedy Institute of Rheumatology has been awarded two major grants this week, one from the European Research Council (ERC) and the other from the Human Frontier Science Program.

Professor Dustin's research at the Kennedy focuses on immunological synapse (IS), a term he first coined to describe the embrace between T cells and B cells that is necessary to mount an immune response.

ERC ADVANCED GRANT

Understanding the immunological synapse is important for innovation in healthcare and the €2.2M Advanced Grant from the ERC will allow Professor Dustin's group at the Kennedy Institute to address fundamental gaps in our understanding of this process.

The five-year project due to start this November aims to reveal the composition of particular structures related to immunological synapses, defined as synaptic ectosomes, as well as identify ways to manipulate their formation.

"These structures add a new dimension to studies on the immunological synapse" says Professor Dustin. "We are very excited to have this opportunity to understand this new phenomenon; we hope to harness what we learn to improve vaccines and immunotherapy."

HUMAN FRONTIER SCIENCE PROGRAM

Professor Dustin is part of an international team of experts who will be investigating the formation of antibodies, key agents in the body's response to pathogens.

Coordinated by Prof Michael Meyer-Hermann, a systems biologist of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, the €1.2 million project is funded by the Human Frontier Science Program (HFSP).

Results from the three-year research project will form the foundation for specific interventions into the immune response to infections.

Professor Dustin says: "This is a very exciting opportunity to combine mathematical models and experiments while overcoming barriers to international collaboration."

The research program will focus on the information processing in the germinal centres, highly organized tissues that are generated by infections and vaccines to protect us, but also may produce self-destructive antibodies in autoimmune diseases.

The research team will develop methods to study and manipulate human germinal centres in unprecedented detail using powerful imaging methods. Previous studies have used experiments in mice, as methods to study human germinal centres were not previously available. This approach will overcome limitations of traditional mouse models to study germinal centers, particularly divergence of important regulatory mechanisms between mouse and man.

Professor Meyer-Hermann and Professor Dustin are joined by Dr Gabriel Victora of the Whitehead Institute for Biomedical Sciences, Cambridge, USA, and Prof Carola Vinuesa of the Australian National University in Canberra.

The Human Frontier Science Program only funds teams from different continents and is aimed specifically at establishing international cooperation.

Similar stories

New children’s orthopaedic hospital opens in Zimbabwe

Main

A new children’s orthopaedic hospital in Bulawayo that will treat children across Zimbabwe who are living with musculoskeletal impairments has opened today.

Professor Katja Simon elected to the Academy of Medical Sciences

Awards Kennedy Main

Professor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.

3,400 different medicines used globally to treat COVID-19

Main Statistics and epidemiology

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.